Evangeli Bista, Co-founder and Head of Operations and Development of Kapa3 \u2013 Cancer Guidance Centre, has been invited to join the Expert Group of the European research and innovation project PATH \u2013 Patient AI Treatment Hub as an independent expert.<\/strong><\/p>\n Her participation is undertaken in a personal and independent capacity<\/strong>, with her professional affiliation to Kapa3 \u2013 Cancer Guidance Centre, creating an opportunity to bring into the European dialogue experience gained through direct engagement with people affected by cancer, survivors, caregivers and healthcare professionals. The PATH Terms explicitly define Expert Group members as acting independently rather than as partners, employees, agents or subcontractors of the Consortium.<\/p>\n PATH \u2013 Patient AI Treatment Hub<\/strong> is a European research and innovation project focused on supporting the safe and effective integration of Artificial Intelligence into cancer care through the development of a secure, interoperable and privacy-preserving digital platform.<\/p>\n The project aims to explore how Artificial Intelligence tools can be safely integrated into cancer-care pathways, supporting healthcare professionals and contributing to more personalised approaches while safeguarding privacy and health data.<\/p>\n At the heart of this effort lies a critical question:<\/p>\n How can technological innovation create meaningful value for patients while preserving trust, human oversight, safety and equity?<\/strong><\/p>\n As a member of the PATH Expert Group, Evangeli Bista will contribute independent expertise, opinions, input, comments and feedback<\/strong> in relation to selected project use cases and activities.<\/p>\n The experience developed through Kapa3’s work can contribute to discussions around issues such as:<\/p>\n Artificial Intelligence is creating new possibilities for healthcare and cancer care. At the same time, its growing use raises important questions concerning trust, transparency, safety, equitable access and human oversight<\/strong>.<\/p>\n For Kapa3, the development of a digital solution cannot begin solely with the question of what is technologically possible.<\/p>\n It must also ask:<\/p>\n What does the patient actually need?<\/strong><\/p>\n Can people understand the information they receive?<\/p>\n Do they know where that information comes from?<\/p>\n Can they trust the system?<\/p>\n Is it clear when Artificial Intelligence is being used and when human professional judgement is required?<\/p>\n Could digital inequalities lead to new inequalities in healthcare?<\/p>\n And ultimately, does innovation genuinely improve the experience and pathway of a person facing cancer?<\/strong><\/p>\n These are questions that we believe should remain at the centre of the European discussion on Artificial Intelligence in healthcare.<\/p>\n Evangeli Bista’s participation in the PATH Expert Group comes at a time when Kapa3 is systematically expanding its work in digital health, patient navigation and the responsible use of emerging technologies to support people affected by cancer<\/strong>.<\/p>\n This broader work also includes MYRTO \u2013 Digital Navigator for Health and Social Rights<\/strong>, an independent Kapa3 initiative developed to help transform complex and often fragmented information on rights, benefits and administrative procedures into more accessible, structured and evidence-based guidance for patients and caregivers.<\/p>\n MYRTO is not part of PATH, and the two initiatives are independent from one another.<\/strong><\/p>\n However, the experience of developing patient-facing digital services has reinforced several principles that Kapa3 considers essential:<\/p>\n reliable information, transparent sources, understandable communication, data protection, human oversight and a clear pathway to professional support when technology alone is not enough.<\/strong><\/p>\n This distinction is also important from an intellectual-property perspective, since the PATH Terms preserve intellectual property that exists independently of the Expert’s Services and is not incorporated into PATH Contributions.<\/p>\n Digital transformation in healthcare is not simply about more data, more algorithms or more applications.<\/p>\n It is about creating greater understanding, better access and stronger trust<\/strong>.<\/p>\n For a person facing cancer, information has value when it can be translated into a meaningful next step.<\/p>\n Technology has value when it reduces \u2014 rather than increases \u2014 complexity.<\/p>\nWhat is PATH \u2013 Patient AI Treatment Hub?<\/h2>\n
Participation in the PATH Expert Group<\/h2>\n
\n
Why the Patient Voice Must Be Part of Innovation<\/h2>\n
Kapa3’s experience in digital health<\/h2>\n
From information to trust<\/h2>\n